Bayer Corporation Unveils Revolutionary Customized Termite Control System.

Business Editors

KANSAS CITY, Mo.--(BUSINESS WIRE)--Feb. 11, 2002

Introduced Today, the Onset of Termite Swarm Season, Bayer Home

Health(TM) Offers Prescriptive Approach Tailored to Each Homeowner's

Existing or Potential Termite Trouble

February marks the unofficial start of termite swarm season, the time when termites begin infesting homes nationwide and causing the destruction that costs American homeowners approximately $2 billion each year.

In the past, the only approach to rid homes of these unwanted houseguests was a one-size-fits-all treatment program. But like each home, each termite infestation is different - which is why Bayer Corporation (NYSE:BAY) has created Bayer Home Health(TM), a totally prescriptive approach to termite control. A complete system comprised of products that can be mixed and matched to treat a home's individual situation, Bayer Home Health provides a total termite protection system that can be custom tailored to a homeowner's level of infestation.

"No matter if a homeowner is facing a serious termite problem or a minor infestation, or if they just want to monitor for peace of mind, they can now turn to Bayer Home Health for the solution to meet their particular needs," said Jeff Vannoy, Pest Management Market Manager for Bayer Professional Care. "The Bayer Home Health family of products delivers the efficacy of Bayer Premise(R), while minimizing drilling and disruption for the more than half a million homeowners inconvenienced by termites each year."

The Bayer Home Health system includes:

    -- PREMISE(R) Termiticide
       The no.1 selling liquid non-repellent termiticide in the
       country, Premise has successfully treated nearly a million
       American homes since its introduction seven years ago.
       Imidacloprid, the active ingredient in PREMISE, destroys
       termites on contact, providing protection that lasts up to
       seven years.

    --  OUTPOST(TM)Termite Detection System (TDS) and Termite Bait
        Response (TBR)
        OUTPOST is designed to help homeowners detect and prevent
        potential termite infestations. OUTPOST TDS monitors are
        strategically placed in the ground surrounding the home to
        detect neighboring termites. Once termites are detected, the
        monitors are filled with OUTPOST TBR. Containing an insect
        growth regulator, the TBR station stops termites' ability to
        molt, killing neighboring termites before they can invade the
        home.

    -- PREMISE(R) Portable Termite Solutions - PREMISE(R) Gel
       PREMISE Gel gives homeowners an instant termite control
       treatment option with pinpoint accuracy. Unlike the messy,
       large bore drilling with most other treatments, Premise Gel
       uses a deep placement injection tool that only requires a
       1/8-inch hole. Placed in termite infestation hotspots like
       windowsills and doorways, the Stabilized Hydrogel(TM)
       technology in PREMISE Gel actually attracts termites,
       delivering powerful protection. One gram of the gel can kill
       more than 2,000 termites.

    -- PREMISE(R) Foam
       Termites need an opening only 1/64th of inch - the size of a
       pinpoint - to enter your home. PREMISE Foam fills gaps you
       can't see around your home and delivers a lethal dose of
       PREMISE to knock out even the toughest termites.

For more information on products within the Bayer Home Health system, homeowners can log on to www.nobugs.com.

Best known for its flagship product, Bayer Aspirin, Bayer Corporation produces a broad range of health care, life sciences and chemical products that help diagnose and treat diseases, purify water, preserve local landmarks, protect crops, advance automobile safety and durability and improve people's lives.

Headquartered in Pittsburgh, Bayer Corporation had sales of $10.1 billion in 2000 and is one of Fortune magazine's Most Admired Companies. The company employs 23,200 people. It is a member of the worldwide Bayer Group, a $29 billion international health care and chemicals group based in Leverkusen, Germany. The Bayer Group stock is a component of the DAX and is listed on the New York Stock Exchange (ticker symbol: BAY).